Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst thumbnail

Pot legislation is more likely in 2020, 2021 than this year: Cannabis analyst

CNBC’s “Squawk Alley” team talks about legislation that would legalize cannabis and what that means for cannabis companies with Vivien Azer, Cowen’s senior cannabis and beverage sector analyst.

Captives of Cannabis: Inside smuggling across U.S. highways thumbnail

Captives of Cannabis: Inside smuggling across U.S. highways

In the latest installment of “Captives of Cannabis,” NBC News’ Jacob Soboroff embeds with an elite drug task force for an inside look at how authorities are trying to stop…

Cannabis reclassification is 'a real milestone' for the industry," says Curaleaf's Boris Jordan thumbnail

Cannabis reclassification is ‘a real milestone’ for the industry,” says Curaleaf’s Boris Jordan

Boris Jordan, co-founder and executive chairman of Curaleaf, joins ‘Squawk on the Street’ to discuss the significance of cannabis’ reclassification, the federal tax code around cannabis, and much more.

Inside one of the biggest cannabis investor conferences thumbnail

Inside one of the biggest cannabis investor conferences

The cannabis buzz. Is regulation a catalyst for pot stocks? Is it time to buy? With FM trader Tim Seymour, CNBC’s Melissa Lee and the Fast Money traders, Dan Nathan,…

U.S. vs. Canadian cannabis stocks: Key distinctions thumbnail

U.S. vs. Canadian cannabis stocks: Key distinctions

Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC thumbnail

Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC

He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC thumbnail

Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC

The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…

Firing up the cannabis trade thumbnail

Firing up the cannabis trade

Trader Tim Seymour on why he’s long a number of cannabis stocks. With CNBC’s Courtney Reagan and the Fast Money traders, Victoria Fernandez and Delano Saporu. For access to live…

Aurora Cannabis chair talks Peltz appointment and the future of the cannabis industry thumbnail

Aurora Cannabis chair talks Peltz appointment and the future of the cannabis industry

Canadian cannabis company Aurora announced that it has appointed hedge fund billionaire Nelson Peltz as a strategic advisor. Aurora Cannabis Executive Chairman Michael Singer joins “Squawk Box” to discuss the…

GW Pharma CEO on new cannabis-derived drug thumbnail

GW Pharma CEO on new cannabis-derived drug

GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says about the future of cannabis-derived drugs.